Indoco Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
For the full year, sales was INR 16,400.5 million compared to INR 15,037.3 million a year ago. Revenue was INR 16,709.5 million compared to INR 15,430.8 million a year ago. Net income was INR 1,422.5 million compared to INR 1,548 million a year ago. Basic earnings per share from continuing operations was INR 15.44 compared to INR 16.8 a year ago. Diluted earnings per share from continuing operations was INR 15.42 compared to INR 16.8 a year ago.